You are here: Industry Insights > Growth

News List

U.S. biopharma CEOs look outside for growth, poll finds fiercepharma
September 26, 2019
Eli Lilly went after Loxo Oncology to beef up its presence in cancer treatment, just as Amgen is paying $13.4 billion for Celgene’s Otezla to secure a larger share of the psoriasis market alongside old TNF drug Enbrel.
Pharmaceutical Chemical Market to Witness Significant Growth europeanpharmaceuticalreview
August 06, 2019
The rise of manufacturing advanced drugs will stimulate growth in the pharmaceutical chemical market.
Bellwyck Pharma Services on Growth Path contractpharma
June 18, 2019
Expands cold storage space in U.S., adds packaging services in EU.
Symbiosis Boosts Business Development Team to Support US Growth contractpharma
June 10, 2019
Helen Caddy-Leach to lead the Scottish CMO’s push into the U.S.
Pharmaceutical intermediates market to see growth europeanpharmaceuticalreview
June 10, 2019
The global pharmaceutical intermediates market is likely to see year-on-year growth in 2019, by an estimated 3.6 percent rate.
European firms fuel growth in patent applications europeanpharmaceuticalreview
March 14, 2019
Pharmaceutical and biotechnology patent applications increased by 13 percent last year, with over 6,000 applications coming from European companies…
Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth en-cphi.cn
March 13, 2019
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma") provided an update on several of its capital projects currently underway in both the United States and Belgium.
Takeda hits FDA snag on Ninlaro, but its growth still helps drive revenue hike fiercepharma
February 02, 2019
In Takeda’s last quarterly report as a separate company from Shire, things seem to be going its way—key drugs are growing nicely, Shire integration is on track, and cash-raising sell-offs are underway, executives said.
J&J reports 2018 fourth-quarter results biospectrumasia
January 24, 2019
Worldwide sales for the full-year 2018 were $81.6 billion, an increase of 6.7% versus 2017
Regeneron's Eylea hits double-digit growth for 2018, and it's 'far from done fiercepharma
January 10, 2019
Investors had been worried that growth for Regeneron’s Eylea was slowing down, but the New York drugmaker kicked off the J.P. Morgan Healthcare Conference with an attempt to allay those fears.

Previous page 1 2 Next page